Mario Thevis German chemist and professor for preventive doping research
Thevis, Mario, 1973-
VIAF ID: 37830184 (Personal)
Permalink: http://viaf.org/viaf/37830184
Preferred Forms
4xx's: Alternate Name Forms (3)
5xx's: Related Names (1)
Works
| Title | Sources |
|---|---|
| Mass spectrometry in sports drug testing, c2010: |
|
| Mildronate |
|
| Mitragynine (Kratom) - monitoring in sports drug testing |
|
| Monitoring 2-phenylethanamine and 2-(3-hydroxyphenyl)acetamide sulfate in doping controls |
|
| Monitoring drug residues in donor blood/plasma samples using LC-(MS)/MS--a pilot study |
|
| N-methyl-N-trimethylsilyltrifluoroacetamide-promoted synthesis and mass spectrometric characterization of deuterated ephedrines |
|
| New drugs and methods of doping and manipulation |
|
| Nutrition Status of Young Elite Female German Football Players |
|
| Nutritional supplements cross-contaminated and faked with doping substances |
|
| Obesity resistance of the stearoyl-CoA desaturase-deficient (scd1-/-) mouse results from disruption of the epidermal lipid barrier and adaptive thermoregulation. |
|
| Optimization of an online heart-cutting multidimensional gas chromatography clean-up step for isotopic ratio mass spectrometry and simultaneous quadrupole mass spectrometry measurements of endogenous anabolic steroid in urine |
|
| Organ distribution of 4-MEC, MDPV, methoxetamine and α-PVP: comparison of QuEChERS and SPE |
|
| Pharmacokinetics and pharmacodynamics of meldonium in exercised thoroughbred horses |
|
| Pilot study on the effects of intravesical oxybutynin hydrochloride instillations on the validity of doping control urine samples |
|
| Plasticizers excreted in urine: indication of autologous blood transfusion in sports |
|
| Post-mortem distribution of the synthetic cannabinoid MDMB-CHMICA and its metabolites in a case of combined drug intoxication. |
|
| Post-mortem vitreous humour as potential specimen for detection of insulin analogues by LC-MS/MS. |
|
| Posttranslational Hydroxylation of Human Phenylalanine Hydroxylase Is a Novel Example of Enzyme Self-Repair within the Second Coordination Sphere of Catalytic Iron |
|
| Potency of Full-Length MGF to Induce Maximal Activation of the IGF-I R Is Similar to Recombinant Human IGF-I at High Equimolar Concentrations |
|
| Potential of GHB phase-II-metabolites to complement current approaches in GHB post administration detection |
|
| Probing for the presence of doping agents in exhaled breath using chromatographic-mass spectrometric approaches |
|
| Proceedings of the Manfred Donike Workshop, 38th Cologne Workshop on Dope Analysis 9th to 14th February 2020 |
|
| Proteolysis and autolysis of proteases and the detection of degradation products in doping control. |
|
| Qualitative and Semiquantitative Analysis of Doping Products Seized at the Swiss Border |
|
| Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS. |
|
| Quantification of urinary AICAR concentrations as a matter of doping controls |
|
| Quantitative determination of metabolic products of 19-norandrostenediol in human plasma using gas chromatography/mass spectrometry |
|
| Rapid screening of polysaccharide-based plasma volume expanders dextran and hydroxyethyl starch in human urine by liquid chromatography-tandem mass spectrometry |
|
| RBC-NOS-dependent S-nitrosylation of cytoskeletal proteins improves RBC deformability |
|
| Reporting and managing elevated testosterone/epitestosterone ratios--novel aspects after five years' experience |
|
| Revisiting the metabolism of 19-nortestosterone using isotope ratio and high resolution/high accuracy mass spectrometry |
|
| RNA interference for performance enhancement and detection in doping control |
|
| Screening and confirmation of myo-inositol trispyrophosphate |
|
| Screening for the calstabin-ryanodine receptor complex stabilizers JTV-519 and S-107 in doping control analysis |
|
| Screening for the synthetic cannabinoid JWH‐018 and its major metabolites in human doping controls |
|
| Sensitive and fast identification of urinary human, synthetic and animal insulin by means of nano-UPLC coupled with high-resolution/high-accuracy mass spectrometry |
|
| SERMs and SARMs: detection of their activities with yeast based bioassays |
|
| Simplifying and expanding analytical capabilities for various classes of doping agents by means of direct urine injection high performance liquid chromatography high resolution/high accuracy mass spectrometry |
|
| Simultaneous determination and validated quantification of human insulin and its synthetic analogues in human blood serum by immunoaffinity purification and liquid chromatography-mass spectrometry |
|
| Single-dose administration of clenbuterol is detectable in Dried Blood Spots |
|
| Solid-phase extraction-liquid chromatography-tandem mass spectrometry method for the qualitative analysis of 61 synthetic cannabinoid metabolites in urine |
|
| Special issue-murders by drugs |
|
| Sports drug testing: Analytical aspects of selected cases of suspected, purported, and proven urine manipulation |
|
| Sports drug testing using complementary matrices: Advantages and limitations |
|
| Stimulants and doping in sport |
|
| Storage-induced changes of the cytosolic red blood cell proteome analyzed by 2D DIGE and high-resolution/high-accuracy MS. |
|
| Structural elucidation of major selective androgen receptor modulator (SARM) metabolites for doping control |
|
| Structure characterisation of urinary metabolites of the cannabimimetic JWH-018 using chemically synthesised reference material for the support of LC-MS/MS-based drug testing |
|
| Structure elucidation of the diagnostic product ion at m/z 97 derived from androst-4-en-3-one-based steroids by ESI-CID and IRMPD spectroscopy |
|
| Studies on the collision-induced dissociation of adipoR agonists after electrospray ionization and their implementation in sports drug testing |
|
| Studies on the in vivo metabolism of the SARM YK11: Identification and characterization of metabolites potentially useful for doping controls |
|
| Synthese und Charakterisierung von Glucuronidkonjugaten anabol-androgener Steroidhormone mittels Gaschromatographie, Massenspektrometrie, Flüssigkeitschromatographie, Massenspektrometrie und kernmagnetischer Resonanzspektroskopie |
|
| Synthetic anabolic agents: steroids and nonsteroidal selective androgen receptor modulators |
|
| Tainted toothpaste - Analytical investigation into an unusual adverse finding |
|
| Targeting prohibited substances in doping control blood samples by means of chromatographic-mass spectrometric methods |
|
| Temporal indication of cannabis use by means of THC glucuronide determination |
|
| Testing for the erythropoiesis-stimulating agent Sotatercept/ACE-011 (ActRIIA-Fc) in serum by means of Western blotting and LC-HRMS. |
|
| Time for change: a roadmap to guide the implementation of the World Anti-Doping Code 2015. |
|
| Toxicology of Specific Substances |
|
| Traditional Chinese medicine and sports drug testing: identification of natural steroid administration in doping control urine samples resulting from musk (pod) extracts |
|
| Trafficking of drug candidates relevant for sports drug testing: Detection of non‐approved therapeutics categorized as anabolic and gene doping agents in products distributed via the Internet |
|
| Unusual mass spectrometric dissociation pathway of protonated isoquinoline-3-carboxamides due to multiple reversible water adduct formation in the gas phase |
|
| Updated protocols for the detection of Sotatercept and Luspatercept in human serum |
|
| Urinary concentrations of morphine and codeine after consumption of poppy seeds |
|
| Validated hemoglobin-depletion approach for red blood cell lysate proteome analysis by means of 2D PAGE and Orbitrap MS. |
|
| Validation of serum IGF-I as a biomarker to monitor the bioactivity of exogenous growth hormone agonists and antagonists in rabbits |
|
| Xenon elimination kinetics following brief exposure |
|
